PubMed HealthSearch

Biomedical subjects

F Hrubá

Publications and source records attributed to F Hrubá.

At least 19 recordsLinked to original sources

The effect of some N solutions for parenteral nutrition on gastric and pancreatic secretion.

In patients without pancreatic disease Aminofusin L forte infused for 1 h did not stimulate gastric or pancreatic secretion. On the other hand, infusion of casein by hydrolysate led to a significant increase in the concentration and total output of HCl. 4 h intravenous infusion of Aminofusin L forte caused a transient but significant rise of the bicarbonate concentration, amylase activity and above all trypsin activity and output. The results show that N solutions used for parenteral protein nutrition influence in a different way both gastric and pancreatic secretion.

Amino Acids

Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus.

A significantly lower vitamin C concentration has been found in the blood and particularly in the leukocytes of hypercholesterolemic diabetic patients than of healthy blood donors. Ascorbic acid administered in a dose of 500 mg per day for 12 months to metabolically stabilized hypercholesterolemic subjects with maturity-onset diabetes mellitus (diabetic diet without insulin or diabetic drugs) brought about a striking decline of cholesterolemia and a moderate decline of triglyceridemia. The serum lipid level in the control group given placebo remained unaltered. A daily administration of 500 mg of ascorbic acid for six months failed to affect the fasting level of serum immunoreactive insulin. It is assumed that the long-term administration of ascorbic acid to maturity-onset diabetics removed the tissue ascorbate deficiency and improved the liver ability to compensate the increased endogenous synthesis of cholesterol by its enhanced transformation to bile acids.

Ascorbic Acid

Effect of ascorbic acid on plasma cholesterol in humans in a long-term experiment.

During the period of a low vitamin C intake (approximately equal to 20 mg per day) ascorbic acid in a dose of 2 x 500 mg per day was administered to 82 men and women aged 50-75 years. A correlation of plasma cholesterol levels determined before and after a three months' administration of ascorbic acid showed the effect of vitamin C to be dependent on the starting concentration of plasma cholesterol: the higher the initial cholesterolemia, the greater the hypocholesterolemic effect of ascorbic acid. On restricting the experimental group to subjects with an initial cholesterolemia above 230 mg%, the effect of the same dose of ascorbic acid on cholesterolemia was followed in three-month periods for a further 9 months. In all these time intervals, ascorbic acid was found significantly to depress cholesterolemia and its effects persisted 6 weeks after termination of the experiment. The administration of 2 x 500 mg ascorbic acid daily during one year resulted in an abrupt increase of ascorbemia and a marked accumulation of ascorbic acid in the leucocytes. Six weeks following interruption of ascorbic acid intake, vitamin C concentration in the leucocytes significantly declined but still continued to be twice higher than in the control receiving no ascorbic acid supplement.

Aged

Effect of hyper- and hypothyroidism on the alpha-tocopherol concentration in serum and some organs of growing rats.

The finding of a raised alpha-tocopherol concentration in the heart muscle, liver, skeletal muscle and serum during experimental hyperthyroidism, lasting 30 days, made the authors assume that this cumulation is a transient phenomenon which would disappear during a prolonged metabolic disorder as a result of energetic breakdown of the organism. The purpose of the paper was to verify this view. The investigation with experimental hyper- and hypothyroidism was made in 120 rats with a mean weight of 160 g. To 60 animals daily 100 mug thyroxin were administered by the i.p. route, 48 animals were given 2.5 Carbimazol daily by mouth to induce hypothyroidism and 12 animals served as controls. The animals were fed the same diet. The effect of the administered preparations was examined after 20, 30, 40, 50 and 60 days. In hypothyroid animals the 50th day was omitted. The results revealed: 1. In hyperthyroid animals the body weight was almost constant to the end of the experiment. However these animals had a significantly raised weight of the heart muscle and liver, as compared with the remaining two groups. 2. In hyperthyroid animals the highest alpha-tocopherol concentration in the heart muscle and skeletal muscle was recorded after 20 days. During subsequent time intervals the alpha-tocopherol concentration in the heart muscle declined gradually. In the skeletal muscle a dramatic decline occurred after 40 days and proceeded to the end of the investigation when the recorded values were at the borderline of detectability. This finding confirmed the authors view that the alpha-tocopherol cumulation in muscle exposed to an increased work load is a transient phenomenon and disappears during prolonged hyperthyroidism before the breakdown of the organism. 3. In hyperthyroidism no correlation was found between the alpha-tocopherol concentration and the lipid content of organs and skeletal muscle. This correlation was found in hypothyroidism. 4. The alpha-tocopherol serum level in hyperthyroidism was significantly higher than in hypothyroidism. 5. In hyperthyroidism the alpha-tocopherol cumulation in liver increased gradually, and reached its maximum after 50 days. At a time when the alpha-tocopherol concentration in the heart muscle and skeletal muscle declined already, its liver concentration increased. This phenomenon may be associated with the increasing protein synthesis in the liver during hyperthyroidism, or with other phenomena which call for further investigation.

Animals